vs
Side-by-side financial comparison of Brixmor Property Group Inc. (BRX) and IDEAYA Biosciences, Inc. (IDYA). Click either name above to swap in a different company.
Brixmor Property Group Inc. is the larger business by last-quarter revenue ($354.8M vs $207.8M, roughly 1.7× IDEAYA Biosciences, Inc.). IDEAYA Biosciences, Inc. runs the higher net margin — 57.4% vs 36.0%, a 21.4% gap on every dollar of revenue.
Brixmor Property Group is a publicly traded real estate investment trust that invests in shopping centers.
IDEAYA Biosciences, Inc. is a clinical-stage biotechnology company focused on oncology, developing targeted therapies and synthetic lethality treatments for patients with genetically defined cancers. It advances a pipeline of candidates across multiple tumor types, partnering with industry stakeholders to accelerate global access to innovative cancer care solutions.
BRX vs IDYA — Head-to-Head
Income Statement — Q1 FY2026 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $354.8M | $207.8M |
| Net Profit | $127.8M | $119.2M |
| Gross Margin | — | — |
| Operating Margin | 37.8% | 52.2% |
| Net Margin | 36.0% | 57.4% |
| Revenue YoY | 5.1% | — |
| Net Profit YoY | 83.2% | 330.1% |
| EPS (diluted) | $0.41 | $1.33 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $354.8M | — | ||
| Q4 25 | $353.8M | — | ||
| Q3 25 | $340.8M | $207.8M | ||
| Q2 25 | $339.5M | — | ||
| Q1 25 | $337.5M | — | ||
| Q4 24 | $328.4M | — | ||
| Q3 24 | $320.7M | $0 | ||
| Q2 24 | $315.7M | $0 |
| Q1 26 | $127.8M | — | ||
| Q4 25 | $137.1M | — | ||
| Q3 25 | $94.2M | $119.2M | ||
| Q2 25 | $85.1M | — | ||
| Q1 25 | $69.7M | — | ||
| Q4 24 | $83.4M | — | ||
| Q3 24 | $96.8M | $-51.8M | ||
| Q2 24 | $70.1M | $-52.8M |
| Q1 26 | 37.8% | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | 52.2% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | 36.0% | — | ||
| Q4 25 | 38.8% | — | ||
| Q3 25 | 27.6% | 57.4% | ||
| Q2 25 | 25.1% | — | ||
| Q1 25 | 20.7% | — | ||
| Q4 24 | 25.4% | — | ||
| Q3 24 | 30.2% | — | ||
| Q2 24 | 22.2% | — |
| Q1 26 | $0.41 | — | ||
| Q4 25 | $0.43 | — | ||
| Q3 25 | $0.31 | $1.33 | ||
| Q2 25 | $0.28 | — | ||
| Q1 25 | $0.23 | — | ||
| Q4 24 | $0.27 | — | ||
| Q3 24 | $0.32 | $-0.60 | ||
| Q2 24 | $0.23 | $-0.68 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $323.9M | $786.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $3.0B | $1.1B |
| Total Assets | $9.1B | $1.2B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $323.9M | — | ||
| Q4 25 | $334.4M | — | ||
| Q3 25 | $331.5M | $786.9M | ||
| Q2 25 | $105.0M | — | ||
| Q1 25 | $106.5M | — | ||
| Q4 24 | $377.6M | — | ||
| Q3 24 | $451.3M | $920.0M | ||
| Q2 24 | $473.6M | $701.7M |
| Q1 26 | — | — | ||
| Q4 25 | $5.5B | — | ||
| Q3 25 | $5.5B | — | ||
| Q2 25 | $5.1B | — | ||
| Q1 25 | $5.1B | — | ||
| Q4 24 | $5.3B | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | $3.0B | — | ||
| Q4 25 | $3.0B | — | ||
| Q3 25 | $3.0B | $1.1B | ||
| Q2 25 | $3.0B | — | ||
| Q1 25 | $3.0B | — | ||
| Q4 24 | $3.0B | — | ||
| Q3 24 | $2.9B | $1.2B | ||
| Q2 24 | $2.9B | $931.7M |
| Q1 26 | $9.1B | — | ||
| Q4 25 | $9.1B | — | ||
| Q3 25 | $9.0B | $1.2B | ||
| Q2 25 | $8.6B | — | ||
| Q1 25 | $8.6B | — | ||
| Q4 24 | $8.9B | — | ||
| Q3 24 | $8.7B | $1.2B | ||
| Q2 24 | $8.7B | $973.7M |
| Q1 26 | — | — | ||
| Q4 25 | 1.83× | — | ||
| Q3 25 | 1.85× | — | ||
| Q2 25 | 1.73× | — | ||
| Q1 25 | 1.73× | — | ||
| Q4 24 | 1.79× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $142.2M |
| Free Cash FlowOCF − Capex | — | $142.2M |
| FCF MarginFCF / Revenue | — | 68.4% |
| Capex IntensityCapex / Revenue | 3.4% | 0.0% |
| Cash ConversionOCF / Net Profit | — | 1.19× |
| TTM Free Cash FlowTrailing 4 quarters | — | $13.5M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $652.0M | — | ||
| Q3 25 | $168.3M | $142.2M | ||
| Q2 25 | $181.5M | — | ||
| Q1 25 | $130.1M | — | ||
| Q4 24 | $624.7M | — | ||
| Q3 24 | $157.5M | $-49.2M | ||
| Q2 24 | $183.5M | $-32.9M |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | $142.2M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $-49.7M | ||
| Q2 24 | — | $-33.9M |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | 68.4% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | 3.4% | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | 0.0% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | — | — | ||
| Q4 25 | 4.75× | — | ||
| Q3 25 | 1.79× | 1.19× | ||
| Q2 25 | 2.13× | — | ||
| Q1 25 | 1.87× | — | ||
| Q4 24 | 7.49× | — | ||
| Q3 24 | 1.63× | — | ||
| Q2 24 | 2.62× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BRX
| Rental income | $354.3M | 100% |
| Other revenues | $482.0K | 0% |
IDYA
Segment breakdown not available.
